课题基金 / 基金详情

FDA DRUG RESIDUE PREVENTION PROGRAM

FDA DRUG RESIDUE PREVENTION PROGRAM
FDA 药物残留预防计划
批准号:
9770851
负责人:
THOMAS DAVID FREW
金额:
$2.6万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2021-06-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
FDA DRUG RESIDUE PREVENTION PROGRAM RFA-FD-18-006 PROJECT SUMMARY OHIO DEPARTMENT OF AGRICULTURE This grant proposal from the Ohio Department of Agriculture (ODA) is in response to Funding Opportunity Announcement RFA-FD-18-006 offered by the Food and Drug Administration (FDA). The purpose of this proposal from ODA is to develop Ohio’s drug residue prevention program with a proactive approach, through continued education and outreach activities to practitioners, producers, firms, and other industry parties involved with treating and / or managing medicated food producing animals, activities related to legal extra label drug use in animals, and other measures related to drug residue prevention in Ohio. This will be achieved through the following objectives: 1. Industry-wide education and outreach, which will consist of ODA’s Veterinarian Administrators attending and presenting at various industry-wide meetings throughout the state; development of information to be available on ODA’s website; and the creation of brochures and factsheets for distribution. 2. On-site assessments with firms who have had violative drug residues within the past year. Assessments will include evaluation the firms’ drug usage and animal medication practices to identify ineffective or improper practices, and to communicate best residue prevention practices with intent to prevent future violations to ensure food safety. 3. On-site best practice visits with firms who have had violative drug residues within the past three years. The focus of the visits will be consistent with assessments, however, will have a heavier focus on best practices moving forward. The goal of the drug residue prevention program is to see more effective management of animal treatment, by increasing the awareness and knowledge of proper drug use and extra label drug use regulations. We would expect to see a continued reduction in illegal drug residues in food-producing animals, with an ultimate goal of zero tissue residue violations in Ohio.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
  • 批准号:
    61372188
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陈秀杰
  • 依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
  • 批准号:
    61073135
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    梅虎
  • 依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
  • 批准号:
    20776012
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2007
  • 负责人:
    张慧
  • 依托单位: